We are a leading healthcare campus encompassing all fields of health: from healthcare and research to teaching and management.
Professionalism, commitment and research by professionals on the Campus are the key elements in offering patients excellent care.
We are committed to research as a tool to provide solutions to the daily challenges we face in the field of medical healthcare.
We generate, transform and transmit knowledge in all areas of the health sciences, helping to train the professionals of the future.
We are defined by our vocation for communication. We invite you to share everything that happens at Vall d'Hebron Barcelona Hospital Campus, and our doors are always open.
This tool has been developed by Eurecat in collaboration with the Vall d’Hebron Campus and was coordinated by the Hospital's Diagnostic Imaging Department within the framework of the Deep Lung project.
The Vall d’Hebron Campus, in collaboration with the Eurecat technology centre, has created a new system for identifying nodules that are indicative of possible lung cancers using a tool based on AI techniques, particularly Deep Learning. The project has been supported by the Centre of Innovation for Data Tech and Artificial Intelligence (CIDAI). Eurecat showcased this new technology at this year's Mobile World Congress.
The technology allows for the refinement of predictive models based on 3D medical imaging, integrated within the radiology workflow, with the aim of “enabling the early detection of the disease and providing a support tool for the prognosis and follow-up by expert medical professionals, representing a breakthrough in precision medicine that is transforming clinical practice and the healthcare sector”, explains Felipe Miralles, director of the Eurecat Digital Health Unit.
The innovation seeks to support radiologists in the monitoring of lung nodules by means of a system that is capable of conducting analyses via Deep Learning; detecting nodules and re-identifying them; and providing a projection of tumour growth and the probability of said tumours being cancerous.
An important aspect of this innovation is the creation of an interface for the temporal analysis of lung nodules and the intuitive and informative visual examination of the results, which helps physicians to provide more accurate diagnoses.
This tool has been developed by Eurecat in collaboration with the Vall d'Hebron Campus, and was coordinated by the Hospital’s Clinical Directorate of Diagnostic Imaging and Nuclear Medicine within the framework of the Deep Lung project. “The aim is to develop an artificial intelligence (AI) tool applied to CT images that will allow for the early detection of lung cancer. This tool is based on the monitoring of suspicious lesions, which are evaluated by radiology specialists at Vall d’Hebron University Hospital. The application of AI in these cases will improve the diagnostic and predictive capacity in patients affected by the disease, and in future screening programmes for lung cancer in the wider population”, concluded Dr Manel Escovar, Clinical Director of the Diagnostic Imaging Department at Vall d'Hebron University Hospital and researcher in the Molecular Medical Imaging Research Group at the Vall d'Hebron Research.
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to email@example.com, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.